Clinical Research Directory
Browse clinical research sites, groups, and studies.
ESP Blocks for Posterior Spinal Fusion
Sponsor: Duke University
Summary
This prospective randomized double-blind study evaluates the efficacy of erector spinae plane (ESP) blocks on postoperative pain in patients undergoing cervical or lumbar posterior spinal fusion. Patients will receive either 0.5% bupivacaine plus liposomal bupivacaine or 0.5% plain bupivacaine. Outcomes include opioid consumption over 72 hours, pain scores, length of stay, and time to ambulation.
Official title: A Double-Blind Prospective RCT Assessment of ESP Blocks for Analgesia Following Posterior Spinal Fusion
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2026-01
Completion Date
2028-01
Last Updated
2025-11-13
Healthy Volunteers
No
Conditions
Interventions
ESP Block with Bupivacaine
Cervical and lumbar ESP blocks performed under ultrasound guidance using plain bupivacaine.
ESP Block with Bupivacaine + Liposomal Bupivacaine
Cervical and lumbar ESP blocks performed under ultrasound guidance using bupivacaine admixed with liposomal bupivacaine.
Locations (1)
Duke University
Durham, North Carolina, United States